These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2833999)

  • 21. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors.
    Stein C; Millan MJ; Shippenberg TS; Peter K; Herz A
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1269-75. PubMed ID: 2539460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions between the discriminative stimulus effects of mu and kappa opioid agonists in the squirrel monkey.
    Negus SS; Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1991 Jan; 256(1):149-58. PubMed ID: 1846412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Similar actions of kappa and mu agonists on spinal nociceptive reflexes in rats and their reversibility by naloxone.
    Parsons CG; West DC; Headley PM
    NIDA Res Monogr; 1986; 75():461-4. PubMed ID: 2828992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opioid inhibition of spontaneously active neurons of the rat arcuate nucleus in vitro.
    Loose MD; Kelly MJ
    Brain Res Bull; 1989 May; 22(5):819-23. PubMed ID: 2548677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Body temperature response profiles for selective mu, delta and kappa opioid agonists in restrained and unrestrained rats.
    Spencer RL; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1988 Jul; 246(1):92-101. PubMed ID: 2839673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ontogeny of mu-, delta- and kappa-opioid receptors mediating inhibition of neurotransmitter release and adenylate cyclase activity in rat brain.
    De Vries TJ; Hogenboom F; Mulder AH; Schoffelmeer AN
    Brain Res Dev Brain Res; 1990 Jun; 54(1):63-9. PubMed ID: 2163782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medial preoptic-anterior hypothalamic area involvement in the suppression of pulsatile LH release by a mu-opioid agonist in the ovariectomized rat.
    Mallory DS; Gallo RV
    Brain Res Bull; 1990 Aug; 25(2):251-7. PubMed ID: 2171721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tonic pain perception in the mouse: differential modulation by three receptor-selective opioid agonists.
    Murray CW; Cowan A
    J Pharmacol Exp Ther; 1991 Apr; 257(1):335-41. PubMed ID: 1850470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analgesic synergy and improved motor function produced by combinations of mu-delta- and mu-kappa-opioids.
    Sutters KA; Miaskowski C; Taiwo YO; Levine JD
    Brain Res; 1990 Oct; 530(2):290-4. PubMed ID: 1979930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective tolerance at mu and kappa opioid receptors modulating norepinephrine release in guinea pig cortex.
    Werling LL; McMahon PN; Cox BM
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1103-6. PubMed ID: 2849659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the antinociceptive and motor effects of intrathecal opioid agonists in the rat.
    Miaskowski C; Sutters KA; Taiwo YO; Levine JD
    Brain Res; 1991 Jul; 553(1):105-9. PubMed ID: 1933267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mu and kappa opiate receptor involvement in agonistic behaviour in mice.
    Benton D
    Pharmacol Biochem Behav; 1985 Nov; 23(5):871-6. PubMed ID: 3001783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo.
    Sheldon RJ; Nunan L; Porreca F
    J Pharmacol Exp Ther; 1987 Oct; 243(1):234-40. PubMed ID: 2822899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different profile of electrocortical power spectrum changes after micro-infusion into the locus coeruleus of selective agonists at various opioid receptor subtypes in rats.
    Bagetta G; De Sarro GB; Sakurada S; Rispoli V; Nisticò G
    Br J Pharmacol; 1990 Nov; 101(3):655-61. PubMed ID: 1963804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
    Capasso A; Sorrentino L
    Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
    Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dexamethasone selective inhibition of acute opioid physical dependence in isolated tissues.
    Capasso A; Di Giannuario A; Loizzo A; Pieretti S; Sagratella S; Sorrentino L
    J Pharmacol Exp Ther; 1996 Feb; 276(2):743-51. PubMed ID: 8632345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The specific opioid kappa-agonist U-50,488H inhibits low Km GTPase.
    Ueda H; Misawa H; Fukushima N; Takagi H
    Eur J Pharmacol; 1987 Jun; 138(1):129-32. PubMed ID: 3040426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opioid receptor subtypes associated with ventral tegmental facilitation and periaqueductal gray inhibition of feeding.
    Jenck F; Quirion R; Wise RA
    Brain Res; 1987 Oct; 423(1-2):39-44. PubMed ID: 2823993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opioid peptides reduce synaptic transmission in the nucleus accumbens.
    Yuan XR; Madamba S; Siggins GR
    Neurosci Lett; 1992 Jan; 134(2):223-8. PubMed ID: 1317025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.